All Posts
How is Telepsychiatry Fulfilling the Evolving Mental Healthcare Demand?
Over the past two years, the coronavirus disease 2019 (COVID-19) pandemic has significantly impacted the global healthcare industry. The pandemic has resulted in a substantial spike in demand for ...
FDA Approves AstraZeneca’s Enhertu; Bayer Wins FDA Approval for Prostate Cancer Therapy, Nubeqa; ...
FDA Approves AstraZeneca’s Enhertu as First Targeted Therapy for HER2-low Cancer Enhertu, developed by AstraZeneca and Daiichi Sankyo, has been approved by the FDA as the first targeted therapy...
Which Pipeline Therapy Has The Potential To Revolutionize The Dystrophic Epidermolysis Bullosa Tr...
Dystrophic epidermolysis bullosa (DEB) is a common skin disease with a chronic history and low healing rates. Despite current management therapies, the disease has the potential to become severe a...
New Approved PML Treatment Options – A Long-awaited Hope for PML Patients
Progressive multifocal leukoencephalopathy is a severe, progressive, and lethal demyelinating disease that presents in immunocompromised states. It is a rare indication, with just over 1.5K PML di...
FDA Clearance to iRhythm’s ZEUS System; Respiri Introduces the Wheezo Device & App; CONMED to...
iRhythm receives FDA clearance for ZEUS System for Zio watch iRhythm Technologies, a leading digital healthcare solutions firm focused on advancing cardiac care, announced that it received FDA ...
How is Artificial Intelligence (AI) Playing a Constructive Role in Mental Health Management?
As per the latest findings, the prevalence of Mental Health has grown significantly over the past two-three decades. The growth has been registered in almost every country worldwide. People of any...
Bristol-Myers Squibb’s Opdivo & Yervoy Combo Trial; Sarepta’s Gene Therapy SRP-9001 for DMD;...
Bristol-Myers Squibb’s Opdivo and Yervoy Combo Fails in Phase III Trial Bristol-Myers Squibb has reported that their Opdivo and Yervoy checkpoint inhibitor combo failed a phase III trial as adj...
Can FcRn Antagonists Be The Game-Changer in the Generalized Myasthenia Gravis (gMG) Treatment Mar...
Though a rare disease, generalized myasthenia gravis (gMG) still affects around 60,000 people in the US and another 100,000 in EU-5 and Japan. As per our analysis, the total diagnosed prevalen...
Advancing Therapeutic Outlook for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Treatment
Key Highlights The US approval of Jynarque added the much-needed push to the ADPKD treatment market.In the coming years, Bardoxolone methyl is expected to be an effective therapy for ADPKD trea...
AbbVie & iSTAR’S Strategic Alliance; Baxter Launches Welch Allyn RetinaVue 100 Imager PRO; I...
ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise™ System for the Treatment of Hypertension On July 26, 2022, ReC...
Editor's Pick
Can denovoSkin Be A Lifesaver for Burn Victims?
Burn is a global public health problem, causing more than 180,000 deaths per year acros...
NexoBrid and its Awaiting US Approval
A Burn takes place when the skin comes into contact with a heat source. Burns can occur...
New Clinical Developments in the Pulmonary Arterial Hypertension Treatment Do...
Pulmonary arterial hypertension is a progressive disease of the lung vascular system, p...
Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...
The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...
Emerging Market for Organ on a Chip
The organ on a chip is a microfluidic culture device that recapitulates the complicated...
-Agonist.png "Toll-like Receptors Agonist")
Sign up For Newsletters
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
